Arthritis drug reduces potency of first vaccine dose ...Egypt

News by : (Masress) -
The first dose of the COVID-19 vaccines from Pfizer/BioNTech and from AstraZeneca Plc produces only weak immune responses in patients being treated with the widely-used rheumatoid arthritis drug infliximab, researchers have found. Infliximab, sold by Johnson & Johnson under the brand name Remicade (...)

Hence then, the article about arthritis drug reduces potency of first vaccine dose was published today ( ) and is available on Masress ( Egypt ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Arthritis drug reduces potency of first vaccine dose )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار